Document is current

Article History

First Online: 29 July 2024

Competing interests

: F.M.F. is a scientific co-founder and equity holder in Proximity Therapeutics; was previously a scientific advisory board member of Triana Biomedicines; and is or was recently a consultant or received speaking honoraria from Eli Lilly, RA Capital, Tocris BioTechne and Plexium Inc. The Ferguson lab receives or has received research funding or resources in kind from Ono Pharmaceutical, Eli Lilly and Merck. F.M.F.’s interests have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies.